Yuki Tachibana
8PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 15, 2026
Structure-Based Drug Discovery of Non-SAM-Mimetic Bisubstrate Inhibitors against Nicotinamide N‑Methyltransferase.Shuhei Yoshida, Noriyasu Kondo, Shota Uehara
|Jul 05, 2025
Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19.Yuto Unoh, Keiichiro Hirai, Shota Uehara
|Nov 17, 2023
Peptide-to-Small Molecule: Discovery of Non-Covalent, Active-Site Inhibitors of β-Herpesvirus Proteases.Shuhei Yoshida, Yusuke Sako, Eiji Nikaido
|Feb 10, 2023
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo.Takayuki Kuroda, Haruaki Nobori, Keita Fukao
|Aug 01, 2022
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model.Haruaki Nobori, Keita Fukao, Takayuki Kuroda
|Jul 29, 2022
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides.Shuhei Yoshida, Shota Uehara, Noriyasu Kondo
Pageof 2
Frequent Collaborators
4 joint publications
Shota Uehara
4 joint publications
Shiho Yamamoto
4 joint publications
Teruhisa Kato
3 joint publications
Shuhei Yoshida
2 joint publications
Haruaki Nobori
1 joint publications
Yoshiyuki Taoda
1 joint publications
Shigeru Ando
1 joint publications
Takao Sanaki
1 joint publications
Yuto Unoh
1 joint publications
Jun Sato
